Chemical industry – Page 83
-
BusinessMissing safety risk emails draw $9bn Actos fine
Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
-
BusinessSun set on Ranbaxy rescue
Acquiring beleaguered firm will create India’s biggest pharmaceutical company
-
Business
GSK investigates bribery claims in the Middle East
Leaked emails claim GlaxoSmithKline bribed Iraqi doctors and healthcare officials
-
Business
Anadarko agrees $5bn clean-up settlement
Record fine will address pollution at mining and manufacturing sites across the US.
-
Business
Contamination troubles strike GSK
GlaxoSmithKline is warned over contamination at an Ireland plant, and has recalled Alli from US retailers over tampering concerns.
-
Business
Lilly wins cancer drug patent dispute
Alimta patent will last until 2022 after US court rules in Lilly’s favour
-
Business
Pharma giants plan new public–private collaborations
AstraZeneca and GSK will partner with UK academics to work on early drug discovery
-
Business
Baxter aims to divide and conquer
Firm will split off its biopharmaceuticals business from medical products
-
Business
Grangemouth will switch to shale gas feed by 2016, says Ineos
New terminal will take US ethane imports and outdated plants will shut down
-
OpinionKnown unknowns
New molecules with unpredictable biological activity deserve sensible amounts of respect, says Derek Lowe
-
Business
AstraZeneca boosts open innovation efforts
Web portal will make collaborative drug discovery easier
-
Business
$1.2bn J&J deceptive marketing fine overturned
Supreme court reverses decision to fine firm over Risperdal promotion
-
BusinessRussian chemical industry to take a hit
Major manufacturer Khimprom to be liquidated with loss of up to 4000 jobs
-
Business
US coal companies fined over water pollution
Comprehensive upgrades required to water treatment systems at mines and processing plants
-
BusinessBumpy road for Chinese renewable energy
Huge losses at star Chinese renewable energy firms are ringing alarm bells
-
Business
US focuses pharma supply chain scrutiny
Import pre-authorisation for trusted firms frees up resources to tackle purity problems
-
Business
UK to fast-track access to critical medicines
Patients could receive medicines before formal approval in exchange for monitoring data
-
Business
Bristol-Myers Squibb to close Irish plant
130 jobs to go at manufacturing site in Cruiserath
-
Business
Minerals Technologies wins tussle over Amcol
US firm outbids European rival Imerys for polymer and speciality minerals supplier